Guidewire Owns the Insurance Policy Record and Is Borrowing 1 Billion Dollars to Own the Pricing Step Too

Cash left for shareholders after capex, capitalized software and all stock pay

$176.8M

Fiscal 2026 (year ended Jul 31, 2026), our calculation

Cash left for shareholders as a share of revenue

12%

Fiscal 2026, our calculation

Stock bought back

$606.3M

Fiscal 2026

1. Our call: Hold off, because Guidewire owns the insurer's policy record but is about to borrow $1.0B to buy an underwriting tool

Our call: Hold off. Guidewire sells the core software that property and casualty insurers use to write policies, bill customers and handle claims, and it had about 550 customers in 44 countries, some of which hold more than one insurance brand at Jul 31, 2026 ^[1].

It prices core subscriptions on the direct written premium an insurer manages on the platform, so it earns more as its customers write more business ^[1].

Fiscal 2026 revenue rose 23% to $1,475.4M, subscription and support revenue rose 33% to $970.9M, and annual recurring revenue reached $1,242M at constant currency, up 19% ^[2]. The company guides fiscal 2027 revenue to $1,707M to $1,727M before any acquisition ^[2].

We measure owner cash, the cash left for shareholders: operating cash flow, less capital spending including capitalized software, less all stock pay. On that measure, cash left for shareholders was $176.8M in fiscal 2026, 12.0% of revenue, our calculation from the 10-K and SEC XBRL ^[1][11].

Two years earlier the figure was $30.6M, and in fiscal 2022 and 2023 it was negative ^[11].

On Oct 27, 2026 Guidewire agreed to buy hyperexponential, a London underwriting and pricing software maker, for a base price of $1.7B in cash plus up to $400.0M more tied to recurring revenue targets, funded by a new $1.0B term loan and cash on hand

2. Research spending is close to a quarter of revenue

2b. Guidewire owns the policy record and is paid on premium

An insurer's policies, billing accounts and claims files sit in Guidewire's PolicyCenter, BillingCenter and ClaimCenter, which makes it the system of record for the insurance contract itself ^[1]. Initial subscriptions generally run five years, with annual renewals after that ^[1].

Two passes and two partials. The gate is strong: replacing a policy system means migrating every live contract and rate, which is why initial terms run five years ^[1].

The partials reflect a crowded field around the core and the fact that the pricing step, where underwriting decisions are made, has until now belonged to partners like hyperexponential ^[1][4].

3. Growth reaccelerated as customers moved to the cloud

The mix is shifting from one-time licenses to subscriptions. Subscription and support revenue was 66% of the total in fiscal 2026, against 61% a year earlier, while license revenue fell 7% to $234.6M ^[1][2].

Fourth quarter revenue grew 15%, slower than the year, as license revenue fell 18% ^[2].

Fully ramped annual recurring revenue, a company measure that includes contracted price steps over the first five years, grew 22% at constant currency to $1,578M ^[2]. That figure runs ahead of current recurring revenue because cloud contracts step up over time ^[2].

Recurring revenue was $1,242M at last year's exchange rates and $1,237M when revalued to Jul 31, 2026 rates; we use the constant currency figure the company guides on ^[2].

4. Large customers drive the numbers

Guidewire's ten largest customers were 21% of fiscal 2026 revenue and 20% of fiscal 2025 revenue, and the ten largest by recurring revenue were 20% of the total at Jul 31, 2026 ^[1]. The September 2026 agreement with a top 10 U.S. carrier adds another name to that top tier, though the company did not change guidance for it ^[8].

The chief financial officer said fiscal 2026 had the lowest gross attrition of recurring revenue since the company began measuring it, which fits a system that is hard to replace ^[2].

The fiscal 2027 guide calls for ending recurring revenue of $1,450M to $1,460M, before hyperexponential, which the company says will add at least 650 basis points to fiscal 2027 recurring revenue growth ^[2][4].

5. Margins widened, but stock pay is still large

GAAP operating income rose to $149.9M in fiscal 2026 from $41.1M, a 10.2% operating margin, our calculation ^[2]. The company guides fiscal 2027 GAAP operating income of $197M to $217M ^[2].

Stock pay was $181.8M in fiscal 2026, 12.3% of revenue, our calculation ^[11]. Non-GAAP operating income of $339.9M leaves that out, along with other items, and we do not use it ^[2].

GAAP net income of $139.3M was reduced by a $22.5M foreign currency loss, against a $16.7M gain a year earlier ^[2]. Interest income also fell by $8.1M as buybacks reduced the cash the company had to invest ^[1].

6. Cash left for shareholders has climbed for four years

Across fiscal 2022 to 2026 shareholders kept a total of $7.8M, our calculation from SEC XBRL ^[11]. Almost all of the improvement came in the last two years, as cloud customers ramped and operating losses turned to profits ^[11].

The company guides fiscal 2027 operating cash flow of $445M to $465M ^[2]. If capital spending and stock pay rise at their fiscal 2026 pace, cash left for shareholders would be roughly $205M to $230M before deal costs, our estimate ^[2][11].

The bull reading is that this is a subscription business reaching scale, with operating cash flow at 26% of revenue in fiscal 2026 ^[2]. The bear reading is that stock pay still takes nearly half of operating cash, 46.7% in fiscal 2026, our calculation, and the deal will add interest costs on top ^[3][11].

7. Buybacks ran more than three times the cash shareholders kept

Guidewire repurchased 4.1 million shares for $606.3M in fiscal 2026, after none in fiscal 2024 or 2025 ^[2][11]. It finished its September 2022 program and approved a new $500.0M program on Jan 8, 2026, with $31.9M left at Jul 31, 2026 ^[2][9].

Cover page share counts fell from 84.5M in August 2025 to 82.0M in August 2026, down 3.0%, our calculation ^[11]. Buybacks of $606.3M against $176.8M of cash left for shareholders were about 3.4 times larger, our calculation, so the company drew down its cash pile ^[2][11].

Cash, cash equivalents and investments fell to $1,215.3M at Jul 31, 2026 from $1,483.2M ^[2]. The company also had $690.0M of convertible senior notes due November 2029 and a $300.0M revolving credit facility ^[1].

The 10-K warns that settling conversions of those notes in stock would dilute existing holders, and holders can convert at any time from Aug 1, 2029 ^[1]

8. The main risks are the deal, the debt and customer concentration

The $1.7B base price is larger than any year of cash left for shareholders in the company's history, and up to $400.0M more depends on recurring revenue targets ^[3][4][11]. Neither the 8-K nor the release discloses hyperexponential's revenue, profit or cash flow, so investors cannot yet judge what the price buys beyond the company's growth claims ^[3][4].

The acquisition agreement is not subject to any conditions to closing and is expected to close in the second quarter of fiscal 2027 ^[3].

The new $1.0B term loan A will be priced at SOFR plus 1.00% to 2.00% depending on leverage ^[3]. Adding it to the $690.0M of convertible notes would put debt near $1.69B, or about 9.6 to 1 against fiscal 2026 cash left for shareholders, our calculation ^[1][3].

Customers can build their own systems, and the 10-K warns that new automation tools may make that easier ^[1]

9. A scaled business taking on its first big debt

Before the deal, Guidewire had reached the point where operating cash flow covered stock pay with room to spare, our reading ^[11]. The hyperexponential purchase changes the balance sheet from net cash to net debt, our calculation ^[1][2][3].

Our base case is organic revenue growth of 14% to 17% a year and cash left for shareholders of $200M to $300M a year over the next two years, before interest on the new loan, our estimate ^[2][11]. That would service the debt, but it leaves less room for buybacks than fiscal 2026 implied.

10. Agents that price risk still need the policy file

A software agent that triages a submission, prices a risk or binds a policy still has to write the result into the insurer's policy system, and at about 550 customers that is Guidewire ^[1]. Pricing on premium means Guidewire earns more if agents help insurers write more business ^[1].

hyperexponential is the step before the policy: its platform handles submission triage, risk assessment, pricing and rating, and it has been used on more than $75B of annual commercial premium ^[4]. Owning it puts Guidewire next to the decision, not just the record ^[4].

The gate would narrow if insurers let outside agents call their pricing models directly and only send finished policies to the core system ^[1]. It would widen if Guidewire's cloud becomes where agents run, since the company already prices some cloud products on usage ^[1].

Guidewire's chief executive came from Salesforce, which the 10-K now lists as a horizontal competitor ^[1][5].

11. A product chief executive, an insurer as chair and a new AXA director

Mike Rosenbaum has been chief executive and a director since August 2019, after product roles at Salesforce, and has served on the board of Docusign since September 2025 ^[5]. John Mullen has been president since February 2022, and Jeff Cooper has been chief financial officer since June 2020 ^[5].

Winston King is chief administrative officer, general counsel and secretary ^[5].

David Peterson, chief accounting officer, told the company on Sep 1, 2026 that he will retire effective Nov 4, 2026, and the company expects Cooper to take on the principal accounting officer duties, subject to board appointment ^[6].

Michael C. Keller, a director since September 2019, has been chairman since March 2024 and the company's Lead Customer Advocate since March 2020 ^[5].

Jeff Sloan, former chief executive of Global Payments and a Corpay director, joined the board in January 2025 ^[10].

Alexander Vollert, former chief operating officer of AXA, joined the board on Aug 1, 2026 ^[7]. Guidewire recognized about $11.3M of revenue from AXA in fiscal 2025 and $13.4M in the nine months to Apr 30, 2026, which the 8-K discloses because of his AXA role

12. The questions we would ask management, and the calls we are tracking

Question one: what recurring revenue and cash flow does hyperexponential bring, and what does it cost to run?

Question two: how fast will the $1.0B term loan be repaid, and will buybacks pause until then?

Question three: how much of license revenue will convert to cloud subscriptions in fiscal 2027?

Question four: what share of revenue comes from usage-priced cloud products?

Question five: what are the targets behind the $400.0M of contingent payments? That answer sets our conviction.

Prediction one: fiscal 2027 total revenue, including the acquisition, exceeds $1,727M (65%).

Prediction two: fiscal 2027 cash left for shareholders, as we define it, is above $200M (60%).

Prediction three: the hyperexponential deal closes by Jan 31, 2027 (85%).

Prediction four: shares outstanding on the next 10-K cover are below 82.0M (45%).

Prediction five: Guidewire repurchases less than $200M of stock in fiscal 2027 (65%).

Filing notes. The acquisition agreement will be filed with the 10-Q for the quarter ending Oct 31, 2026 ^[3].

The 8-K says the deal is not subject to closing conditions ^[3]. Guidewire will update fiscal 2027 guidance for the deal on its December 2026 earnings call ^[4].

Bottom line: Guidewire owns the policy record, but the deal and its debt now set the pace

Guidewire holds the policy, billing and claims records for about 550 customers, prices on their premium, and produced $176.8M of cash left for shareholders in fiscal 2026 after stock pay ^[1][11]. It spent 3.4 times that on buybacks and now plans to borrow $1.0B toward a $1.7B purchase of hyperexponential, taking debt to about 9.6 to 1 against cash left for shareholders ^[2][3].

We would move to Buy if fiscal 2027 cash left for shareholders tops $250M and organic recurring revenue growth holds above 15% while the term loan comes down. A slowdown in organic growth below 12%, or a write-down tied to the deal, would move us to Avoid.

Our call: Hold off, conviction 3 of 5.